Stockholders’ Deficit (Tables)
|
12 Months Ended |
Jun. 30, 2026 |
| Stockholders’ Deficit [Abstract] |
|
| Schedule of Common Stock Issued Upon Completion of the Reverse Recapitalization |
The following table presents the number of the Company’s common stock issued upon completion of the Reverse Recapitalization: | | | Shares of Common | | | | | Stock | | | ACAC’s common stock outstanding prior to Reverse Recapitalization | | | 3,971,634 | | | Less: redemption of ACAC’s common stock | | | (1,744,663 | ) | | Common stock issued to underwriter | | | 43,125 | | | Total common stock issued upon completion of the Reverse Recapitalization | | | 2,270,096 | |
|
| Schedule of Total Stock Based Compensation Expenses |
The following table presents the total stock-based compensation expenses included in each of the respective expense line items for the periods presented: | | | For the Years Ended | | | | | June 30, | | | | | 2026 | | | 2025 | | | | | | | | | | | Selling expenses | | $ | 307,458 | | | $ | 175,332 | | | General and administrative expenses | | | 690,393 | | | | 448,511 | | | Research and development expenses | | | 263,703 | | | | 191,835 | | | Total stock-based compensation expenses | | $ | 1,261,554 | | | $ | 815,678 | |
|
| Schedule of Restricted Stock Units Granted |
The following table summarizes the activity for all restricted stock units granted for the years ended Juen 30, 2026 and 2025: | | | Shares | | | Weight average grant date fair value | | | Total fair value | | | Weighted average remaining contractual term (in years) | | | Unvested at July 1, 2024 | | | - | | | $ | - | | | $ | - | | | | - | | | Granted | | | 727,009 | | | | 7.21 | | | | 5,243,400 | | | | 4.00 | | | Vested | | | - | | | | - | | | | - | | | | - | | | Forfeited | | | (33,080 | ) | | | 7.30 | | | | (241,484 | ) | | | - | | | Unvested at June 30, 2025 | | | 693,929 | | | | 7.21 | | | | 5,001,916 | | | | 3.36 | | | Granted | | | - | | | | - | | | | - | | | | - | | | Vested | | | (260,595 | ) | | | 7.22 | | | | (1,882,417 | ) | | | - | | | Forfeited | | | (44,180 | ) | | | 7.30 | | | | (322,514 | ) | | | - | | | Unvested at June 30, 2026 | | | 389,154 | | | $ | 7.19 | | | $ | 2,796,985 | | | | 2.36 | |
|
| Schedule of Warrants Activity |
The summary of warrants activity is as follows: | | | Warrants Outstanding | | | Common Stock Issuable | | | Weighted Average Exercise Price | | | Average Remaining Contractual Life | | | June 30, 2024 | | | - | | | | - | | | $ | - | | | | - | | | Granted | | | 12,156,417 | | | | 12,156,417 | | | $ | 11.50 | | | | 5.00 | | | Forfeited | | | - | | | | - | | | $ | - | | | | - | | | Exercised | | | (10,500 | ) | | | (10,500 | ) | | $ | 11.50 | | | | - | | | June 30, 2025 | | | 12,145,917 | | | | 12,145,917 | | | $ | 11.50 | | | | 4.24 | | | Granted | | | - | | | | - | | | $ | - | | | | - | | | Forfeited | | | - | | | | - | | | $ | - | | | | - | | | Exercised | | | - | | | | - | | | $ | - | | | | - | | | June 30, 2026 | | | 12,145,917 | | | | 12,145,917 | | | $ | 11.50 | | | | 3.24 | |
|